Sienna Biopharmaceuticals (SNNAQ) Financial Statements

Sienna Biopharmaceuticals's market cap is currently $31.00. The company's EPS TTM is $; its P/E ratio is ―; Sienna Biopharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.